J
Synthesis
D. Diamante et al.
Paper
13
+
C NMR (100 MHz, CDCl ): δ = 164.2, 158.5, 137.8, 137.7, 135.6,
HRMS (ESI): m/z [M + Na] calcd for C19H18N NaO S: 409.0829; found:
2 5
3
135.0, 134.5, 128.7, 127.9, 127.6, 127.1, 126.7, 125.3, 121.1, 43.8, 39.2.
409.0840.
+
HRMS (ESI): m/z [M + Na] calcd for C18H16N NaO S: 379.0723; found:
2
4
379.0709.
(E)-4-(1,1-Dioxido-3-oxobenzo[d]isothiazol-2(3H)-yl)-N-(4-nitro-
benzyl)but-2-enamide (4e)
(
E)-4-(1,1-Dioxido-3-oxobenzo[d]isothiazol-2(3H)-yl)-N-(4-meth-
Following GP2 with amide 1e (1.0 equiv, 65 mg, 0.29 mmol) and sac-
charin (C) (2.0 equiv, 108 mg, 0.59 mmol) for 48 h. The crude product
was purified by flash chromatography on silica gel (eluent: EtOAc/cy-
clohexane, 1:1) to afford 4e in 30% yield (35 mg, 0.09 mmol).
ylbenzyl)but-2-enamide (4b)
Following GP2 with amide 1b (1.0 equiv, 100 mg, 0.53 mmol) and sac-
charin (C) (2.0 equiv, 193 mg, 1.05 mmol) for 24 h. The crude product
was purified by flash chromatography on silica gel (eluent: EtOAc/cy-
clohexane, 1:1) to afford 4b in 33% yield (64 mg, 0.17 mmol).
Beige solid; mp 168–169 °C.
IR (ATR): 3291, 2924, 1735, 1519, 1344, 1259, 968, 730 cm–1
.
White solid; mp 171–172 °C.
IR (ATR): 3291, 2922, 1731, 1621, 1334, 1186 cm–1
1
H NMR (400 MHz, CDCl ): δ = 8.11–8.08 (m, 2 H), 8.00 (ddd, J = 7.3,
3
.
1.4, 0.7 Hz, 1 H), 7.89–7.77 (m, 3 H), 7.39–7.35 (m, 2 H), 6.88 (td, J =
5.4, 15.3 Hz, 1 H), 6.07 (td, J = 1.7, 15.3 Hz, 1 H), 5.93 (br s, 1 H), 4.52
1
H NMR (400 MHz, CDCl ): δ = 8.01–7.98 (m, 1 H), 7.87–7.77 (m, 3 H),
3
(d, J = 6.3 Hz, 2 H), 4.44 (dd, J = 1.7, 5.4 Hz, 2 H).
7
.10–7.04 (m, 4 H), 6.83 (td, J = 5.4, 15.2 Hz, 1 H), 5.99 (td, J = 1.7, 15.2
Hz, 1 H), 5.66 (br s, 1 H), 4.41 (dd, J = 1.7, 5.4 Hz, 2 H), 4.37 (d, J = 5.6
Hz, 2 H), 2.25 (s, 3 H).
13
C NMR (100 MHz, CDCl ): δ = 164.5, 158.6, 147.4, 145.4, 137.7,
3
136.6, 135.1, 134.6, 128.3, 127.0, 126.1, 125.4, 123.9, 121.1, 42.9, 39.2.
13
+
C NMR (100 MHz, CDCl ): δ = 164.2, 158.5, 137.7, 137.3, 135.5,
HRMS (ESI): m/z [M + Na] calcd for C18H15N NaO S: 424.0574; found:
3
3
6
135.0, 134.7, 134.5, 129.4, 127.9, 127.1, 126.8, 125.3, 121.1, 43.6, 39.2,
424.0584.
21.1.
+
HRMS (ESI): m/z [M + Na] calcd for C19H18N NaO S: 393.0879; found:
Methyl (E)-[4-(Benzylamino)-4-oxobut-2-en-1-yl](tert-butyl-
2
4
393.0876.
sulfinyl)carbamate (5a)
Following GP2 with amide 1a (1.0 equiv, 100 mg, 0.57 mmol) and
methyl (tert-butylsulfinyl)carbamate (D) (2.0 equiv, 204 mg, 1.14
mmol) for 48 h. The crude product was purified by flash chromatog-
raphy on silica gel (eluent: EtOAc/cyclohexane, 1:1) to afford 5a in
(
E)-4-(1,1-Dioxido-3-oxobenzo[d]isothiazol-2(3H)-yl)-N-(4-meth-
oxybenzyl)but-2-enamide (4c)
Following GP2 with amide 1c (1.0 equiv, 100 mg, 0.49 mmol) and sac-
charin (C) (2.0 equiv, 178 mg, 0.97 mmol) for 24 h. The crude product
was purified by flash chromatography on silica gel (eluent: EtOAc/cy-
clohexane, 1:1) to afford 4c in 57% yield (106 mg, 0.27 mmol).
47% yield (93 mg, 0.26 mmol).
Yellow oil.
IR (ATR): 3327, 2951, 1702, 1670, 1494, 1371, 1250, 1033 cm–1
.
White solid; mp 164–165 °C.
IR (ATR): 3293, 2933, 1734, 1513, 1182, 909, 730 cm–1
1
H NMR (400 MHz, CDCl ): δ = 7.35–7.27 (m, 5 H), 6.80 (td, J = 5.5,
3
.
15.4 Hz, 1 H), 6.08 (br s, 1 H), 5.95 (td, J = 1.6, 15.3 Hz, 1 H), 4.46 (d, J =
5.7 Hz, 2 H), 4.12 (ddd, J = 1.7, 5.4, 16.9 Hz, 1 H), 3.94 (ddd, J = 1.7, 5.4,
1
1
H NMR (400 MHz, CDCl ): δ = 8.09 (ddd, J = 0.7, 1.5, 7.2 Hz, 1 H),
3
6.9 Hz, 1 H), 3.77 (s, 3 H), 1.21 (s, 9 H).
7.97–7.85 (m, 3 H), 7.23–7.20 (m, 2 H), 6.93 (td, J = 5.4, 15.3 Hz, 1 H),
13
6.88–6.85 (m, 2 H), 6.08 (td, J = 1.7, 15.2 Hz, 1 H), 5.74 (br s, 1 H), 4.51
C NMR (100 MHz, CDCl ): δ = 164.9, 155.4, 139.3, 138.0, 128.7,
3
(dd, J = 1.7, 5.5 Hz, 2 H), 4.44 (d, J = 5.6 Hz, 2 H), 3.80 (s, 3 H).
127.9, 127.5, 125.7, 60.2, 53.6, 43.7, 39.1, 22.5.
13
+
C NMR (100 MHz, CDCl ): δ = 164.1, 159.1, 158.5, 137.7, 135.5,
HRMS (ESI): m/z [M + Na] calcd for C17H24N NaO S: 375.1349; found:
3
2
4
135.0, 134.5, 129.9, 129.3, 127.1, 126.7, 125.3, 121.2, 114.1, 55.3, 43.3,
375.1334.
39.2.
+
HRMS (ESI): m/z [M + Na] calcd for C19H18N NaO S: 409.0829; found:
Methyl (E)-(tert-Butylsulfinyl){4-[(4-methylbenzyl)amino]-4-
2
5
409.0836.
oxobut-2-en-1-yl}carbamate (5b)
Following GP2 with amide 1b (1.0 equiv, 100 mg, 0.53 mmol) and
methyl (tert-butylsulfinyl)carbamate (D) (2.0 equiv, 190 mg, 1.06
mmol) for 30 h. The crude product was purified by flash chromatog-
raphy on silica gel (eluent: EtOAc/cyclohexane, 6:4) to afford 5b in
(
E)-4-(1,1-Dioxido-3-oxobenzo[d]isothiazol-2(3H)-yl)-N-(3-meth-
oxybenzyl)but-2-enamide (4d)
Following GP2 with amide 1d (1.0 equiv, 100 mg, 0.48 mmol) and sac-
charin (C) (2.0 equiv, 178 mg, 0.97 mmol) for 48 h. The crude product
was purified by flash chromatography on silica gel (eluent: EtOAc/cy-
clohexane, 1:1) to afford 4d in 82% yield (154 mg, 0.4 mmol).
27% yield (51 mg, 0.14 mmol).
Yellow oil.
IR (ATR): 3295, 2925, 1717, 1674, 1634, 1443, 1307, 1089, 907, 729
–
1
White solid; mp 138–140 °C.
cm .
IR (ATR): 3287, 2921, 1731, 1625, 1331, 1213, 1013 cm–1
.
1
H NMR (400 MHz, CDCl ): δ = 7.12–7.05 (m, 4 H), 6.73 (ddd, J = 5.4,
3
1
6.1, 15.4 Hz, 1 H), 5.83 (td, J = 1.6, 15.3 Hz, 1 H), 5.73 (br s, 1 H), 4.37
H NMR (400 MHz, CDCl ): δ = 8.11–8.02 (m, 1 H), 7.95–7.87 (m, 3 H),
.25 (dd, J = 7.5, 9.0 Hz, 1 H), 6.93 (td, J = 5.4, 15.3 Hz, 1 H), 6.82–6.84
3
(d, J = 5.7 Hz, 2 H), 4.04 (ddd, J = 1.5, 6.1, 16.9 Hz, 1 H), 3.87 (ddd, J =
7
1
.7, 5.5, 16.9 Hz, 1 H), 3.70 (s, 3 H), 2.26 (s, 3 H), 1.14 (s, 9 H).
(m, 3 H), 6.10 (td, J = 1.7, 15.2 Hz, 1 H), 5.80 (br s, 1 H), 4.52 (dd, J = 1.7,
13
5
.4 Hz, 2 H), 4.48 (d, J = 5.7 Hz, 2 H), 3.80 (s, 3 H).
C NMR (100 MHz, CDCl ): δ = 164.7, 155.4, 139.3, 137.3, 134.9,
3
1
3
129.4, 128.0, 125.8, 60.2, 53.6, 43.6, 39.1, 29.7, 22.5.
C NMR (100 MHz, CDCl ): δ = 164.2, 159.9, 158.5, 139.3, 137.8,
3
1
1
35.7, 135.0, 134.5, 129.8, 127.1, 126.7, 125.4, 121.0, 120.2, 113.4,
13.2, 55.2, 43.8, 39.2.
HRMS (ESI): m/z [M + K]+ calcd for C18H26KN O S: 405.1245; found:
2
4
405.1232.
©
Georg Thieme Verlag Stuttgart · New York — Synthesis 2016, 48, A–M